| Product NDC: | 0469-1602 |
| Proprietary Name: | Vaprisol |
| Non Proprietary Name: | conivaptan hydrochloride |
| Active Ingredient(s): | 20 mg/100mL & nbsp; conivaptan hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0469-1602 |
| Labeler Name: | Astellas Pharma US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021697 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081008 |
| Package NDC: | 0469-1602-10 |
| Package Description: | 1 CONTAINER in 1 CARTON (0469-1602-10) > 100 mL in 1 CONTAINER |
| NDC Code | 0469-1602-10 |
| Proprietary Name | Vaprisol |
| Package Description | 1 CONTAINER in 1 CARTON (0469-1602-10) > 100 mL in 1 CONTAINER |
| Product NDC | 0469-1602 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | conivaptan hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20081008 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | CONIVAPTAN HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/100mL |
| Pharmaceutical Classes | Antidiuretic Hormone Antagonists [MoA],Vasopressin Antagonist [EPC] |